CEDSS: “Building a Scalable Clinical Genomics Program: How tumor, normal, and plasma DNA sequencing are informing cancer care, cancer risk, and cancer detection” Michael Berger, Ph.D. Elizabeth and Felix Rohatyn Chair & Associate Director[...]
PHIND Seminar Series: Multi-Cancer Early Detection Screening Tests – “Liquid Biopsy Tests” – Are Here – But Will Payers Provide Insurance Coverage? Patricia A. Deverka, MD, MS, MBE Executive Director Deverka Consulting, LLC [...]